
Identifying undiagnosed rare-disease patients is a near-term goal

More evidence that drug abusers are at risk from counterfeiters

Company may have erroneously been operating under a generic classification

Packaging materials from Sonoco ThermoSafe enabled the sustainability program

New company is to be known as QuintilesIMS

Drug dispensing, point of care testing and diagnostics are beneficiaries

Drug Channel’s analysis of Inc. 5000 shows some eye-popping growth

Is your shipper bear-proof?

CIS by Deloitte seeks to provide a comprehensive service for revenue management

Mylan CEO sticks to authorized-generic strategy for price relief

Roche could overtake Novartis as the No. 1 global firm by then, says Evaluate Pharma

Acquires PharmaPort assets from AAR

Pharmacy benefit managers feel some marketplace heat even as they establish new benefit programs

Partnership with Jeena & Co., a leading provider

In first year, the product has six of Top 20 companies as clients

Walgreens-Rite Aid merger is still pending

Largest industry gathering for temperature-controlled logistics and distribution

Serialization and traceability mandates move forward there; anti-counterfeiting is also a focus

New study finds payer cost savings for patients with comorbidities

Zephyr Health adds Referral and Segment Analytics to its Illuminate data service

EpiPen controversy has a new twist: paying lower rebates to state Medicaid programs

A newly designed label for vials and other containers prevents illicit reuse of pharma containers

Acquisition expands CSafe’s manufacturing capacity in Europe

Xyntek and Antares Vision build a serialization solution


The growing market for self-administered injectables calls for better patient-training resources

A host of evaluation methodologies are defining ‘value’ in drug prices

Existing incentives continue to draw in new drug developers; payers begin to look at competitive markets to drive down drug costs
